Our Work
Latham & Watkins Advises Summit Partners on Sale of RadioOnkologieNetzwerk
December 6, 2021
The buyer is Medipass, a portfolio company of DWS Group.
Latham & Watkins LLP has advised Summit Partners on the sale of RadioOnkologieNetzwerk (RON), a leading radiotherapy platform provider in Germany. The buyer is Medipass, a portfolio company of DWS Group.
The Latham team includes Frankfurt partner Otto von Gruben, Hamburg partners Jörn Kowalewski and Nils Röver, with associates Daniel Kreutzmann and Florian Doster. Advice was also provided on tax matters by partner Tobias Klass; on antitrust matters by Frankfurt partner Max Hauser and Düsseldorf associate Leonie Spangenberger.